Cargando…
Nonalcoholic fatty liver disease: another leap forward
In 2020, there have been substantial advances in nonalcoholic fatty liver disease mechanisms, diagnostics and treatment. Key developments include the identification of a cellular and tissue signature to provide new insights into pathophysiology, advancements in non-invasive diagnostics and publicati...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7791336/ https://www.ncbi.nlm.nih.gov/pubmed/33420415 http://dx.doi.org/10.1038/s41575-020-00406-0 |
| _version_ | 1783633591362650112 |
|---|---|
| author | Abdelmalek, Manal F. |
| author_facet | Abdelmalek, Manal F. |
| author_sort | Abdelmalek, Manal F. |
| collection | PubMed |
| description | In 2020, there have been substantial advances in nonalcoholic fatty liver disease mechanisms, diagnostics and treatment. Key developments include the identification of a cellular and tissue signature to provide new insights into pathophysiology, advancements in non-invasive diagnostics and publication of interim results of the first phase III trial to demonstrate improvement in hepatic fibrosis. |
| format | Online Article Text |
| id | pubmed-7791336 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-77913362021-01-08 Nonalcoholic fatty liver disease: another leap forward Abdelmalek, Manal F. Nat Rev Gastroenterol Hepatol Year in Review In 2020, there have been substantial advances in nonalcoholic fatty liver disease mechanisms, diagnostics and treatment. Key developments include the identification of a cellular and tissue signature to provide new insights into pathophysiology, advancements in non-invasive diagnostics and publication of interim results of the first phase III trial to demonstrate improvement in hepatic fibrosis. Nature Publishing Group UK 2021-01-08 2021 /pmc/articles/PMC7791336/ /pubmed/33420415 http://dx.doi.org/10.1038/s41575-020-00406-0 Text en © Springer Nature Limited 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
| spellingShingle | Year in Review Abdelmalek, Manal F. Nonalcoholic fatty liver disease: another leap forward |
| title | Nonalcoholic fatty liver disease: another leap forward |
| title_full | Nonalcoholic fatty liver disease: another leap forward |
| title_fullStr | Nonalcoholic fatty liver disease: another leap forward |
| title_full_unstemmed | Nonalcoholic fatty liver disease: another leap forward |
| title_short | Nonalcoholic fatty liver disease: another leap forward |
| title_sort | nonalcoholic fatty liver disease: another leap forward |
| topic | Year in Review |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7791336/ https://www.ncbi.nlm.nih.gov/pubmed/33420415 http://dx.doi.org/10.1038/s41575-020-00406-0 |
| work_keys_str_mv | AT abdelmalekmanalf nonalcoholicfattyliverdiseaseanotherleapforward |